Trinity compound research profile
Bronchogen
Bronchogen is a very short, lab-made peptide made of just four amino acids — Alanine, Glutamic acid, Aspartic acid, and Leucine, abbreviated AEDL...
Research overview
Bronchogen is a very short, lab-made peptide made of just four amino acids — Alanine, Glutamic acid, Aspartic acid, and Leucine, abbreviated AEDL (Molecules 2021). It belongs to a family of peptides called "bioregulators" developed by a Russian scientist named Vladimir Khavinson, who created a whole series of these tiny peptides that are each claimed to specifically target a particular organ — in this case, the lungs and airways (bronchi).
Mechanism under study
Instead of locking onto a typical hormone receptor like most peptides, Bronchogen is proposed to work by directly attaching to your DNA and to structures called histones (proteins that DNA wraps around), essentially nudging certain genes on or off — this is called an "epigenetic" effect, meaning it's about controlling which genes get used, not changing the genes themselves (Biochemistry (Mosc) 2011). In lab studies, it appeared to switch on specific genes involved in keeping lung and airway cells healthy and functioning correctly.
Human evidence summary
No human clinical trials of Bronchogen have been identified at all. Everything currently known comes from lab dish experiments and animal studies — there's a complete gap when it comes to actual human testing.
Preclinical evidence summary
In rats given a chemical that damages the lungs to mimic COPD, one month of Bronchogen treatment reversed several signs of lung damage: it fixed an overgrowth of mucus-producing cells, reduced abnormal changes in lung lining cells, restored the tiny hair-like structures (cilia) that sweep out debris, boosted a protective immune antibody, and balanced out inflammatory chemical signals in the airways (Bull Exp Biol Med 2015; Ross Fiziol Zh 2017). Separately, in lab dish experiments with aging human bronchial cells, it activated certain genetic markers linked to healthy cell development (Bull Exp Biol Med 2012). Importantly, this research has all come from essentially one research group, and no independent lab outside that group has repeated or confirmed these findings.
Source material
Use the linked publications and records to evaluate study design, population, limitations, and relevance.